Clinical Trial: PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer

U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933251) titled 'PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer' on March 06.

Brief Summary: This is a single-center, open-label, single-arm clinical study aimed at conducting a preliminary evaluation of the efficacy and safety of combining PCSK9 inhibitors and PD-1 inhibitors (dual inhibitors) with neoadjuvant chemoradiotherapy in patients with pMMR/MSS locally advanced rectal cancer.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Locally Advanced Rectal Cancer (LARC)

Intervention: DRUG: Neoadjuvant Chemoradiotherapy Combined with PD-1 inhibitor Immun...